Cellebrite DI (CLBT) Competitors

Dynatrace (NYSE:DT) and Cellebrite DI (NASDAQ:CLBT) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations.

Which has more volatility & risk, DT or CLBT?

Dynatrace has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Comparatively, Cellebrite DI has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500.

Does the media favor DT or CLBT?

In the previous week, Cellebrite DI had 3 more articles in the media than Dynatrace. MarketBeat recorded 11 mentions for Cellebrite DI and 8 mentions for Dynatrace. Dynatrace's average media sentiment score of 0.62 beat Cellebrite DI's score of 0.60 indicating that Dynatrace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dynatrace	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Cellebrite DI	4 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable earnings & valuation, DT or CLBT?

Dynatrace has higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than Dynatrace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatrace	$1.56B	10.36	$154.63M	$0.55	98.64
Cellebrite DI	$385.17M	11.94	-$81.10M	-$1.55	-14.41

Is DT or CLBT more profitable?

Dynatrace has a net margin of 10.44% compared to Cellebrite DI's net margin of -82.28%. Cellebrite DI's return on equity of 122.59% beat Dynatrace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatrace	10.44%	9.73%	6.09%
Cellebrite DI	-82.28%	122.59%	14.49%

Do analysts recommend DT or CLBT?

Dynatrace presently has a consensus price target of $61.88, suggesting a potential upside of 14.06%. Cellebrite DI has a consensus price target of $20.57, suggesting a potential downside of 7.88%. Given Dynatrace's higher possible upside, research analysts clearly believe Dynatrace is more favorable than Cellebrite DI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynatrace	0 Sell rating(s)	6 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.76
Cellebrite DI	0 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do insiders & institutionals believe in DT or CLBT?

94.3% of Dynatrace shares are held by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are held by institutional investors. 0.6% of Dynatrace shares are held by insiders. Comparatively, 5.7% of Cellebrite DI shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Does the MarketBeat Community prefer DT or CLBT?

Dynatrace received 199 more outperform votes than Cellebrite DI when rated by MarketBeat users. Likewise, 67.23% of users gave Dynatrace an outperform vote while only 63.93% of users gave Cellebrite DI an outperform vote.

Company	Underperform	Outperform
Dynatrace	Outperform Votes 238 67.23%	Underperform Votes 116 32.77%
Cellebrite DI	Outperform Votes 39 63.93%	Underperform Votes 22 36.07%

Summary

Dynatrace beats Cellebrite DI on 11 of the 18 factors compared between the two stocks.